| Literature DB >> 31001749 |
Masaki Kaihara1, Satoru Matsuda2,3, Eisuke Booka1, Fumitaka Saida1, Jumpei Takashima1, Hanako Kasai1, Koki Mihara1, Atsushi Nagashima1,4, Tomohisa Egawa1.
Abstract
BACKGROUND: Open completion gastrectomy (OCG) has been selected to treat remnant gastric cancer (RGC) due to severe adhesions and difficulty recognizing anatomical orientation after primary gastrectomy. In general, elderly individuals' physiological reserves gradually decrease. Moreover, elderly patients (EPs) often have multiple complicating factors (i.e., frailty and comorbidities), leading to more postoperative complications after abdominal surgery. Recently, several trials revealed the advantages of laparoscopic surgery for EPs with gastric cancer in early recovery. However, there are limited studies investigating the use of laparoscopic completion gastrectomy (LCG) for RGC in EPs. This study aims to assess the efficacy of LCG in EPs aged ≥ 70 years. We compared the short- and long-term outcomes of LCG with those of OCG. CASEEntities:
Keywords: Elderly patients; Laparoscopic completion gastrectomy; Remnant gastric cancer
Year: 2019 PMID: 31001749 PMCID: PMC6473005 DOI: 10.1186/s40792-019-0610-0
Source DB: PubMed Journal: Surg Case Rep ISSN: 2198-7793
Fig. 1The placement of surgical ports
Preoperative evaluation using the G-8 geriatric screening tool
| Items (possible answers: score) | LCG | OCG |
|
|---|---|---|---|
| Decrease in food intake in the past 3 months | 0.159 | ||
| Severe: 0 | 0 | 0 | |
| Moderate: 1 | 0 | 4 (27%) | |
| No decrease: 2 | 6 (100%) | 11 (73%) | |
| Weight loss in the past 3 months | 0.347 | ||
| > 3 kg: 0 | 0 | 2 (13%) | |
| Does not know: 1 | 0 | 0 | |
| Between 1 and 3 kg: 2 | 0 | 0 | |
| No weight loss: 3 | 6 (100%) | 13 (87%) | |
| Mobility | 0.105 | ||
| Bed or chair bound: 0 | 0 | 0 | |
| Able to get out of bed and chair but does not go out: 1 | 1 (17%) | 0 | |
| Goes out: 2 | 5 (83%) | 15 (100%) | |
| Neuropsychological problems | 0.516 | ||
| Severe dementia or depression: 0 | 0 | 0 | |
| Mild dementia or depression: 1 | 0 | 1 (7%) | |
| No mental problems: 2 | 6 (100%) | 14 (93%) | |
| Body mass index | 0.182 | ||
| < 19: 0 | 2 (33%) | 1 (7%) | |
| 19–21: 1 | 2 (33%) | 5 (33%) | |
| 21–23: 2 | 0 | 6 (40%) | |
| > 23: 3 | 2 (33%) | 3 (20%) | |
| More than three prescribed medications | 0.576 | ||
| Yes: 0 | 2 (33%) | 7 (47%) | |
| No: 1 | 4 (67%) | 8 (53%) | |
| Self-perception of health | – | – | – |
| Not as good: 0 | |||
| Does not know: 0.5 | |||
| As good: 1 | |||
| Better: 2 | |||
| Age | 0.125 | ||
| > 85: 0 | 1 (17%) | 0 | |
| 80–85: 1 | 2 (33%) | 2 (13%) | |
| < 80: 2 | 3 (50%) | 13 (87%) | |
| Modified score (median, range) | 12.5, 11.3–13.8 | 13.0, 12.0–13.5 | 0.841 |
LCG laparoscopic completion gastrectomy, OCG open completion gastrectomy
Preoperative patient characteristics
| LCG | OCG |
| |
|---|---|---|---|
| Sex | 0.014 | ||
| Male | 2 (33%) | 13 (87%) | |
| Female | 4 (67%) | 2 (13%) | |
| ASA-PS class | 0.526 | ||
| I | 4 (67%) | 8 (53%) | |
| II | 1 (17%) | 1 (7%) | |
| III | 1 (17%) | 6 (40%) | |
| IV | 0 | 0 | |
| V | 0 | 0 | |
| ECOG-PS | 0.105 | ||
| 0 | 1 (17%) | 0 | |
| 1 | 5 (83%) | 15 (100%) | |
| 2 | 0 | 0 | |
| 3 | 0 | 0 | |
| Original disease | 0.291 | ||
| Malignant | 4 (67%) | 13 (87%) | |
| Benign | 2 (33%) | 2 (13%) | |
| Previous approach | 0.022 | ||
| Open | 3 (50%) | 14 (93%) | |
| Laparoscopic | 3 (50%) | 1 (7%) | |
| Previous reconstruction | 0.844 | ||
| B-I | 4 (67%) | 8 (53%) | |
| B-II | 1 (17%) | 4 (27%) | |
| R-Y | 1 (17%) | 3 (20%) | |
| Time interval (years; median, range) | 15.5, 2.3–37.8 | 7.0, 3.5–28.0 | 0.907 |
LCG laparoscopic completion gastrectomy, OCG open completion gastrectomy, ASA-PS American Society of Anesthetists-physical status, ECOG-PS Eastern Cooperative Oncology Group performance status, B-I Billroth-I reconstruction, B-II Billroth-II reconstruction, R-Y Roux-en-Y reconstruction
Pathological findings, surgical outcomes, and postoperative course
| LCG | OCG |
| |
|---|---|---|---|
| Operative time (min; median, range) | 310.5, 249.5–337.8 | 263.0, 241.5–325.0 | 0.791 |
| Blood loss (ml; median, range) | 50, 20.0–65.0 | 465, 264.5–714.0 | 0.002 |
| Open conversion, | 1 (17%) | 0 | 0.105 |
| Number of retrieved LNs (median, range) | 7, 4–10 | 3, 1–6 | 0.171 |
| pT | 0.869 | ||
| T1 | 2 (33%) | 5 (33%) | |
| T2 | 0 | 0 | |
| T3 | 1 (17%) | 4 (26%) | |
| T4 | 3 (50%) | 6 (40%) | |
| pN | 0.642 | ||
| N0 | 6 (100%) | 13 (87%) | |
| N1 | 0 | 1 (7%) | |
| N2 | 0 | 1 (7%) | |
| N3 | 0 | 0 | |
| pM | 0.347 | ||
| M0 | 6 (100%) | 13 (87%) | |
| M1 | 0 | 2 (13%) | |
| pStage | 0.562 | ||
| IA | 2 (33%) | 5 (33%) | |
| IB | 0 | 0 | |
| IIA | 1 17%) | 3 (20%) | |
| IIB | 0 | 0 | |
| IIIA | 3 (50%) | 3 (20%) | |
| IIIB | 0 | 0 | |
| IIIC | 0 | 2 (13%) | |
| IV | 0 | 2 (13%) | |
| Postoperative hospitalization (days; median, range) | 9, 7.3–13.8 | 9, 8.5–17.5 | 0.410 |
| Intake of solid food (days; median, range) | 4, 3.3–4.0 | 3, 3.0–4.0 | 0.867 |
| Postoperative complication (C-D grade ≥ II) | 3 (50%) | 5 (33%) | 0.477 |
| Mortality within 30 days after surgery | 0 | 0 | – |
LCG laparoscopic completion gastrectomy, OCG open completion gastrectomy, LN lymph node, C-D Clavien–Dindo
Fig. 2Overall survival. There was no significant difference in overall survival between the LCG and OCG groups. LCG laparoscopic completion gastrectomy, OCG open completion gastrectomy
Comparison of the modified G8 geriatric screening tool scores in patients with or without postoperative complications
| Postoperative complication (C-D grade ≥ II) |
| ||
|---|---|---|---|
| Present ( | None ( | ||
| Modified G8 geriatric screening tool score (median, range) | 13, 11.0–14.0 | 13, 12.8–13.3 | 0.654 |
C-D Clavien–Dindo
Surgical outcomes in patients with the history of gastrectomy for gastric cancer as primary surgery in the LCG group
| Lymphadenectomy for primary surgery | D2 ( | D1+/D1 ( |
|
|---|---|---|---|
| Operative time (min; median, range) | 352.0, 349.0–355.0 | 271.5, 250.8–292.3 | 0.333 |
| Blood loss (ml; median, range) | 30, 20–40 | 190, 130–250 | 0.333 |
| Open conversion, | 0 | 1 (50%) | 0.248 |
| Postoperative hospitalization (days; median, range) | 9, 8.5–9.5 | 12, 9.5–14.5 | 1 |
| Intake of solid food (days; median, range) | 4.0, 4.0–4.0 | 2.5, 2.4–2.8 | 0.221 |
| Postoperative complication (C-D grade ≥ II) | 1 (50%) | 0 | 0.248 |
| Mortality within 30 days after surgery | 0 | 0 | – |
C-D Clavien–Dindo